Maria Angelica Lupisan
Family · Canton, OHNPI 1437737566
Payments from drug & device makers
Across 332 payments — averaging $15.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Boehringer Ingelheim$497
- Bayer$387
- AstraZeneca$355
- Lilly USA, LLC$295
- Novo Nordisk$279
- plus $2K from 29 others
What the payments were for
- Food & beverage$5,14099%
- Education$661%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 77 | $1,051 |
| Boehringer Ingelheim | 37 | $497 |
| Bayer | 24 | $387 |
| AstraZeneca | 21 | $355 |
| Lilly USA, LLC | 19 | $295 |
| Novo Nordisk | 19 | $279 |
| Axsome Therapeutics, Inc. | 8 | $262 |
| GSK | 17 | $257 |
| Pfizer | 15 | $256 |
| Exact Sciences | 13 | $228 |
| Biohaven Pharmaceutical Holding Company Ltd. | 13 | $187 |
| Xeris Pharmaceuticals, Inc. | 8 | $134 |
| Merck | 8 | $119 |
| Astellas Pharma US Inc | 3 | $112 |
| Corium, LLC | 6 | $102 |
| Amgen | 5 | $83 |
| Biohaven Pharmaceuticals, Inc. | 6 | $82 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $75 |
| Supernus Pharmaceuticals, Inc. | 5 | $71 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $38 |
| Vanda Pharmaceuticals Inc. | 2 | $36 |
| Johnson & Johnson | 2 | $34 |
| Corcept Therapeutics | 2 | $32 |
| Idorsia Pharmaceuticals US Inc | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| Phathom Pharmaceuticals, Inc. | 2 | $26 |
| Mylan Specialty L.p. | 1 | $24 |
| VBI Vaccine (delaware) Inc. | 1 | $20 |
| Pulmonx Corporation | 1 | $19 |
| Ardelyx, Inc. | 1 | $16 |
| Optinose US, Inc. | 1 | $15 |
| Neos Therapeutics, LP | 1 | $15 |
| Cranial Technologies, Inc | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $12 |
| Adlon Therapeutics L.p. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,206 in reported general payments places this provider in the 90th percentile of 6,812 family providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 37 | $36,535 |
| JardianceEmpagliflozin | 16 | $19,925 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 19 | $15,705 |
| FarxigaDapagliflozin Propanediol | 16 | $14,951 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 18 | $7,914 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 47 | $871 |
| Metformin Hcl ErMetformin Hcl | 24 | $550 |
| Rosuvastatin Calcium | 32 | $511 |
| Omeprazole | 42 | $486 |
| Atorvastatin Calcium | 71 | $471 |
| Pregabalin | 13 | $407 |
| Amlodipine Besylate | 37 | $339 |
| Levothyroxine Sodium | 35 | $307 |
| Buspirone Hcl | 18 | $273 |
| Lisinopril | 26 | $252 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $295 | $36,53537 claims |
| AstraZenecaFarxiga, Bevespi Aerosphere | $355 | $22,86534 claims |
| Boehringer IngelheimJardiance | $497 | $19,92516 claims |
| GSKTrelegy Ellipta | $257 | $15,70519 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,812 family providers in Ohio.
Other family in Canton
- Brittany McClainCanton$17K
- Eileen FauldsLewis Center$991K
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
- Renee OttSandusky$179K
- Megan MillerSpringfield$156K
- George KnightCincinnati$130K
- Jillian HuntCincinnati$116K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.